rhAFGF
Commercial- Indications
- Deep third degree burns, Chronic ulcer wounds
Company intelligence / Profile preview
Shanghai Tenry Pharmaceutical has several approved biological drugs in China, notably recombinant human acidic fibroblast growth factor for external use indicated for wound healing. The company also markets recombinant interferons for neoplastic indications. Additional programs are in preclinical or IND stages targeting wounds and injuries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Tenry Pharmaceutical Co., Ltd..